1. Phototherapy alters the oncogenic metabolic activity of breast cancer cells
   Mehdi Shakibaie et al, 2020, Photodiagnosis and Photodynamic Therapy CrossRef
2. Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine
   Trishna Saha Detroja et al, 2022, International Journal of Molecular Sciences CrossRef
3. HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p/USP6/GLS1 axis
   Xiaowen Chen et al, 2022, Cell Death & Disease CrossRef
4. Compound 968 reverses adriamycin resistance in breast cancer MCF-7ADR cells via inhibiting P-glycoprotein function independently of glutaminase
   Ronghui Yang et al, 2021, Cell Death Discovery CrossRef
5. lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis
   Lin Zhu et al, 2021, Acta Biochimica et Biophysica Sinica CrossRef
6. Targeting GLS1 to cancer therapy through glutamine metabolism
   Wei Yu et al, 2021, Clinical and Translational Oncology CrossRef
7. Cancer combination therapies with artemisinin-type drugs
   Thomas Efferth, 2017, Biochemical Pharmacology CrossRef
8. The Glutaminase Inhibitor Compound 968 Exhibits Potent In vitro and In vivo Anti-tumor Effects in Endometrial Cancer
   Xiugui Sheng et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
9. Role of microRNA-146a in cancer development by regulating apoptosis
   Keihan Kookli et al, 2024, Pathology - Research and Practice CrossRef
10. Glutaminase (GLS1) gene expression in primary breast cancer
    Neelima Vidula et al, 2023, Breast Cancer CrossRef
11. Sensitization of melanoma cells to temozolomide by overexpression of microRNA 203 through direct targeting of glutaminase-mediated glutamine metabolism
    X. Chang et al, 2017, Clinical and Experimental Dermatology CrossRef
12. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy
    Chioniso P. Masamha et al, 2018, Journal of Cellular Biochemistry CrossRef
13. Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes
    José M. Matés et al, 2020, Current Medicinal Chemistry CrossRef
14. Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells
    Wei-Qun Lu et al, 2017, Oncotarget CrossRef
15. Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer
    Xingbin Hu et al, 2023, Cancer Communications CrossRef
16. Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells
    Lian Chen et al, 2016, Oncotarget CrossRef